Retinal diseases Clinical Trials

10 recruitingLast updated: May 21, 2026

There are 10 actively recruiting retinal diseases clinical trials across 4 countries. Studies span Not Applicable, Phase 2, Phase 1, Early Phase 1. Top locations include Beijing, Beijing Municipality, China, Durham, North Carolina, United States, Brussels, Brussels Capital, Belgium. Updated daily from ClinicalTrials.gov.


Retinal diseases Trials at a Glance

10 actively recruiting trials for retinal diseases are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Beijing, Durham, and Brussels. Lead sponsors running retinal diseases studies include Center for Eye Research Australia, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, and Beijing Tongren Hospital.

Browse retinal diseases trials by phase

About Retinal diseases Clinical Trials

Looking for clinical trials for Retinal diseases? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Retinal diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Retinal diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Defining Retinal Structures Using Hyperspectral Retinal Imaging

Retinal diseasesHealthy VolunteersAge-Related Macular Degeneration+2 more
Center for Eye Research Australia1,000 enrolled1 locationNCT07555574
Recruiting
Not Applicable

Optimizing Low Vision Rehabilitation in Emotionally Distressed Patients With Inherited Retinal Diseases

Inherited Retinal Diseases
University of Michigan180 enrolled1 locationNCT06651736
Recruiting
Not Applicable

4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800

Retinal diseasesOcular DiseasesCorneal Diseases
Duke University5 enrolled1 locationNCT07024719
Recruiting
Phase 2

SGLT2 Inhibitors in Geographic Atrophy

Geographic AtrophyRetinal diseasesRetinal Degeneration+2 more
Washington University School of Medicine70 enrolled1 locationNCT07174687
Recruiting
Phase 1Phase 2

A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)

Retinitis PigmentosaChoroideremiaNon-Syndromic Rod-Dominant Inherited Retinal Diseases
Kiora Pharmaceuticals, Inc.48 enrolled3 locationsNCT05282953
Recruiting

DISCOVER Study: Microscope-integrated Intraoperative OCT Study

Retinal diseasesEpiretinal MembraneRetinal Detachment+2 more
The Cleveland Clinic3,000 enrolled1 locationNCT02423213
Recruiting
Not Applicable

Arterial Spin Labeling MRI for Assessing Blood Perfusion in the Human Eye Repeatability Study and Clinical Application

Retinal diseases
Cliniques universitaires Saint-Luc- Université Catholique de Louvain70 enrolled1 locationNCT05724641
Recruiting
Early Phase 1

Safety and Efficacy Study of PUMCH-E101 Injection in Subjects with RDH12 Retinopathy

Inherited Retinal Diseases
Peking Union Medical College Hospital10 enrolled1 locationNCT06749639
Recruiting
Phase 1Phase 2

Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene Mutations (STAR)

Leber Congenital AmaurosisInherited Retinal Diseases Caused by RPE65 Mutations
HuidaGene Therapeutics Co., Ltd.20 enrolled3 locationsNCT05906953
Recruiting

Real-world of AI in Diagnosing Retinal Diseases

Retinal diseasesArtificial Intelligence
Beijing Tongren Hospital100,000 enrolled1 locationNCT05981950